| Literature DB >> 12100449 |
Eberhard Ritz, Ralf Dikow, Marcin Adamzcak, Martin Zeier.
Abstract
Cardiac disease is common in dialysis patients. Survival is poorest in the subgroup with systolic dysfunction (pump failure). Audits show that cardiovascular management of dialysis patients in general, and treatment of congestive heart failure (CHF) specifically, is generally not in agreement with recommendations based on evidence obtained from controlled trials, admittedly in nonrenal patients. The pathophysiology underlying CHF and the rationale underlying interventions are discussed in an effort to heighten awareness of this important clinical problem in the dialysis community.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12100449 DOI: 10.1046/j.1525-139x.2002.00044.x
Source DB: PubMed Journal: Semin Dial ISSN: 0894-0959 Impact factor: 3.455